The Excedr Blog
Enhance your lab operations and funding strategies with actionable advice on equipment leasing, financing, procurement, and life sciences industry trends.
Lila Sciences Builds Scientific Superintelligence Through Autonomous AI Labs
Lila Sciences pioneers autonomous AI labs, raising $550M to build scientific superintelligence—Excedr covers this major biotech funding round.
October 2025
Kailera Therapeutics Raises $1 Billion to Challenge the Obesity Market
Kailera Therapeutics raises $1B to advance KAI-9531 obesity drug—Excedr covers this major biotech funding round.
October 2025
Expedition Therapeutics Raises Funds to Target COPD
Expedition Therapeutics secures $165M Series A to advance EXPD-101, a first-in-class oral DPP-1 inhibitor for COPD—Excedr covers this major biotech funding round.
October 2025
Lumen Bioscience: Revolutionizing Biologic Drug Manufacturing with Spirulina
Lumen Bioscience pioneers affordable oral biologic drugs using engineered spirulina—Excedr covers this major biotech funding round.
October 2025
Ansa Biotechnologies Secures Funding to Revolutionize DNA Synthesis
Ansa Biotechnologies secures $54M+ Series B to advance enzymatic DNA synthesis—Excedr covers this major biotech funding round.
October 2025